vTv Therapeutics Inc. (VTVT)

vTv Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	86.64	88.93	36.75	9.45	12.13	13.42
Short-Term Investments	-	-	-	0.07	0.02	0.1
Cash & Short-Term Investments	86.64	88.93	36.75	9.51	12.14	13.52
Cash Growth	234.25%	142.02%	286.35%	-21.66%	-10.17%	120.91%
Accounts Receivable	-	-	-	0.1	0.17	0.06
Other Receivables	-	-	-	-	-	0.14
Receivables	-	-	-	0.1	12.42	0.19
Prepaid Expenses	0.42	0.63	1.15	1.04	2.54	1.91
Other Current Assets	0.53	0.34	0.22	-	-	-
Total Current Assets	87.59	89.89	38.11	10.66	27.09	15.62
Property, Plant & Equipment	-	-	-	0.36	0.56	0.68
Long-Term Investments	-	-	-	-	5.59	9.17
Other Long-Term Assets	0	0.01	0.15	-	-	-
Total Assets	87.59	89.9	38.27	11.02	33.24	25.47

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	6.99	1.13	0.94	4.08	2.46	1.88
Accrued Expenses	-	5.43	4.09	6.17	4.85	6.15
Short-Term Debt	-	-	-	0.19	0.22	0.26
Current Portion of Leases	-	-	0.17	0.17	0.15	0.18
Current Unearned Revenue	-	-	-	0.02	0.02	0.04
Other Current Liabilities	0.03	0.08	-	-	-	-
Total Current Liabilities	7.02	6.64	5.2	10.62	7.71	8.5
Long-Term Leases	-	-	-	0.17	0.34	0.49
Long-Term Unearned Revenue	1.83	18.67	18.67	18.67	18.67	-
Other Long-Term Liabilities	0.11	0.15	0.1	0.11	0.68	1.26
Total Liabilities	8.96	25.46	23.97	29.57	27.4	10.25

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.04	0.04	0.03	0.03	0.03	0.9
Additional Paid-In Capital	394.21	391.09	311.89	256.34	254.76	238.19
Retained Earnings	-315.61	-326.69	-299.72	-281.04	-265.52	-248.83
Total Common Equity	78.63	64.44	12.2	-24.68	-10.74	-9.74
Minority Interest	-	-	2.1	6.13	16.58	24.96
Shareholders' Equity	78.63	64.44	14.3	-18.55	5.84	15.22
Total Liabilities & Equity	87.59	89.9	38.27	11.02	33.24	25.47

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	-	-	0.17	0.53	0.72	0.93
Net Cash (Debt)	86.64	88.93	36.58	8.98	11.43	12.58
Net Cash Growth	235.27%	143.14%	307.23%	-21.38%	-9.20%	141.84%
Net Cash Per Share	7.64	10.56	6.34	4.31	5.95	8.03
Filing Date Shares Outstanding	12.42	12.41	6.58	2.43	2.04	1.67
Total Common Shares Outstanding	12.41	12.41	6.58	2.08	2.04	1.67
Working Capital	80.57	83.25	32.92	0.04	19.39	7.12
Book Value Per Share	6.34	5.19	1.85	-11.84	-5.27	-5.82
Tangible Book Value	78.63	64.44	12.2	-24.68	-10.74	-9.74
Tangible Book Value Per Share	6.34	5.19	1.85	-11.84	-5.27	-5.82
Machinery	-	-	-	0.12	0.12	0.1
Leasehold Improvements	-	-	-	0.41	0.41	0.41

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Aug 6, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 22, 2026

Data Sources Report a data error